The DaCosta Lab AML program was awarded the Princess Margaret Research Stimulus Grant (RSG) for the project titled, “Unlocking the Potential of AML-Targeted Treatments: Harnessing the Power of In Vivo Optical Imaging Technology.”
The RSG is designed to enable PM researchers to accelerate their programs and continue investing in bold and high-gain projects. Its purpose is to propel innovative, fundamental and discovery cancer research and support imminent expenditure and needs of research programs.
We thank the Princess Margaret Research Institute for its continued support of our programs.